This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Glactone Pharma Development Ab. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Ritha Gidlöf: Innovator in Cancer Treatment
Introduction
Ritha Gidlöf is a prominent inventor based in Lund, Sweden. She has made significant contributions to the field of cancer treatment through her innovative research and development.
Latest Patents
Ritha Gidlöf holds 1 patent for her invention titled "Tricyclic lactones for treatment of cancer." This patent discloses novel compounds that are useful for inhibiting IL-6/STAT signaling and/or PI3K/NF-κB signaling in the treatment of associated diseases or conditions, particularly cancer. The invention also includes a pharmaceutical composition comprising these novel compounds, along with its use and a method thereof.
Career Highlights
Ritha is currently associated with Glactone Pharma Development AB, where she continues her work in pharmaceutical innovation. Her research focuses on developing effective treatments that target critical signaling pathways involved in cancer progression.
Collaborations
Ritha collaborates with notable colleagues, including Martin Johansson and Olov Sterner, who contribute to her research efforts and the advancement of cancer therapies.
Conclusion
Ritha Gidlöf's work exemplifies the impact of innovative research in the medical field, particularly in the fight against cancer. Her contributions are paving the way for new therapeutic options that could significantly improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile